ArticleOncotarget2022

Correction: THBS2 as a prognostic biomarker for patients diagnosed with metastatic pancreatic ductal adenocarcinoma.

Phyllis A Gimotty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.